Abstract: Cancer is a major cause of death in the world Oral cancer has posed a challenge to us with its incidence as high as around 20% of total body cancers 7% of all cancer deaths in males and 4% in females have been reported to be due to oral malignancy recent meta-analyses indicate that concurrent chemoradiation yields an 8% absolute increase in overall survival at 5 years compared to radiotherapy alone. The aim is to study the outcome of concurrent chemo-radiation with cisplatin in advanced case of oral malignancy. • Dental evaluation and chest X-ray and X-ray mandible.
1.Introduction
Cancer is a major cause of death in the world. Cancer is often silent, hence diagnosis may not be possible until quite late but oral lesions can be readily inspected and be easily inspected, measured, biopsied and documented. Objective response to treatment can be easily appreciated.
Oral cancer has posed a challenge to us with its incidence as high as around 20% of total body cancers. It is one of the ten leading cancers in the World. In India it is one of the most common cancers and is an important public health problem. About 56000 new cases have been estimated to occur each year, which would lead to more than 100000 individuals suffering from the disease in the population in any given year, furthermore 7% of all cancer deaths in males and 4% in females have been reported to be due to oral malignancy 1 Oral cancers are many a times preceded a premalignant lesion.
Failure of local control of disease is the usual cause of death in patients with advanced stage oral cavity tumours. If combination of chemotherapy and radiotherapy could substantially reduce the bulk of a tumour without prejudicing its blood supply, and hence its oxygenation.
Although primary modalities of definitive treatment with curative intent are radiation and surgery, these approaches fail to cure a sizeable percentage of patients. Consequently, use of combined chemotherapeutic agents and radiotherapy is being considered as another modality of treatment, especially as adjuvant therapy. The role of chemotherapy and raditherapy at present is palliative only in advanced oral cancer. In this preliminary clinical trial-conducted in our Unit, we have found that combination of radiotherapy and chemotherapy is effective as primary treatment modality in oral cavity cancer and palliation of symptoms.
2.Aims
To study outcome of concurrent chemo-radiation with cisplatin in advanced case of oral malignancy.
3.Objectives
 Treatment feasibility can be assessed.  To know the result of this combination in advanced oral malignancy. 
Inclusion Criterias

Treatment Plan Scheme
Radiotherapy protocol: All patients will be treated by Cobalt-60 Teletherapy unit machine. The radiation dose delivered will be 66 Gy in 33Fr (2 Gy/Fr, 5 days in a week). The spinal cord will be shielded after 46 Gy in 23 Fr in some cases depending upon the initial treatment technique use.
Chemotherapy Protocol:
The drug cisplatin is used a single agent concurrently with radiotherapy. The dosage that will be used in 30mg/m 2 weekly for 6 cycles on same day of week. Premedication with dexamethasone, ranitidine and anti-emetics like granisetron will be given before cisplatin infusion. Adequate hydration consisting of dextrose normal saline added with KCL and mgso4 will be given before cisplatin infusion to body surface area will be added to normal saline and is given over 2 to 3 hrs IV infusion. Myelosuppression and renal toxicity will be evaluating by doing complete hemogram, blood urea and serum creatinine weekly.
Follow-Up:
The first follow up will be done at 4 weeks after the completion of treatment. During follow up the patients will be assessed for response of the primary. An attempt to follow up will be made each month till 6 months. 4. The karnofsky scale should be >50 5. The Patient must have platelet count more than 1,00,000/mm 3 , white blood cell count more than 5000/mm 3 and the haemoglobin more than 8gm% 6. Liver function test should be less than one standard deviation above normal. 7. Renal function must be within normal limit. The patient will be submitted for first dose in the first cycle. 11. The next cycle is to be repeated after one week on same day for 6 cycle. 12. Every time the clinical and laboratory work up will be done thoroughly and the next close is omitted at slightest suspicion of the toxicity.
Patient
Only objective response will be considered in assessing overall response, Response categories will includes: 1) Complete response: Complete disappearance of all clinical evidence of primary tumour and secondaries in lymph nodes. 2) Partial Response: A greater than 50% reduction in the product of two perpendicular dimensions or 50% reduction in squared diameter of primary site.. 3) Any regression less than 100% but more than 50% will also be evaluated as partial response. 4) Any regression less than 50% but more than 25% will be evaluated as less than partial response (LPR). 
5.Observation
The study included 50 of advanced oral cavity malignancy which came to our hospital during two years Nov.2013 to June 2015.
Age distribution revealed that there were no cases below age 30 yrs and above 80 yrs. 
Age distribution in advanced oral cavity cancer
6.Discussion
The incidence of oral cavity cancer its distribution in the cavity, it's age incidence and sex ratio all very widely in different nations and races with difference in their nutritional status, their customs, their habit , their occupation and their awareness of general health and hygiene.
In our country the incidence of oral cavity cancer is very high as compared to western countries. Parmaster 2 quotes an incidence of 45% of taotal cancers in india. Similarly Jussawalla quotes the incidence of 37.5% of all cancers. Local and regional control were better in the combined therapy than in group given radiotherapy alone. (95% confidence interval). The estimated two year rate of local and regional control was 82% in the combined therapy as compared in radiotherapy group alone i.e. 72% as written in New England Journal of Medicine.
Age Distributiion:
In this series, the age range encountered is between 30 to 80 years. commenst were 4 th , 5 th decades. The average age is 52 yrs. Spiro quotes median age a 60 yrs.
